Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 3,86k | 0,00 | Derivative Exercise and Retained Stock | - | 46,82k | 8,99% |
| 2026-05-20 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -2,16k | 2,66k | Derivative Exercise and Sale | 1,23 | 46,82k | - |
| 2026-05-20 | Dr. Michael SumnerChief Medical Officer & Head of Development | -2,69k | 3,31k | Derivative Exercise and Sale | 1,23 | 42,04k | - |
| 2026-05-20 | Dr. Michael SumnerChief Medical Officer & Head of Development | 6,76k | 0,00 | Derivative Exercise and Retained Stock | - | 42,04k | 19,15% |
| 2026-05-20 | Mr. Peter D. KiesCFO | 4,01k | 0,00 | Derivative Exercise and Retained Stock | - | 43,23k | 10,23% |
| 2026-05-20 | Mr. Peter D. KiesCFO | -4,69k | 5,77k | Derivative Exercise and Sale | 1,23 | 43,23k | - |
| 2026-05-20 | Dr. Jacqueline E. SheaCEO, President & Director | 15,99k | 0,00 | Derivative Exercise and Retained Stock | - | 111,02k | 16,83% |
| 2026-05-20 | Dr. Jacqueline E. SheaCEO, President & Director | -12,31k | 15,14k | Derivative Exercise and Sale | 1,23 | 111,02k | - |
| 2026-05-15 | Mr. Peter D. KiesCFO | 2,20k | 0,00 | Derivative Exercise and Retained Stock | - | 39,22k | 5,94% |
| 2026-05-15 | Mr. Peter D. KiesCFO | -2,57k | 3,34k | Derivative Exercise and Sale | 1,30 | 39,22k | - |
| 2026-05-15 | Dr. Jacqueline E. SheaCEO, President & Director | 10,03k | 0,00 | Derivative Exercise and Retained Stock | - | 95,03k | 11,80% |
| 2026-05-15 | Dr. Jacqueline E. SheaCEO, President & Director | -7,72k | 10,03k | Derivative Exercise and Sale | 1,30 | 95,03k | - |
| 2026-05-15 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 3,06k | 0,00 | Derivative Exercise and Retained Stock | - | 42,96k | 7,67% |
| 2026-05-15 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -1,71k | 2,23k | Derivative Exercise and Sale | 1,30 | 42,96k | - |
| 2026-05-15 | Dr. Michael SumnerChief Medical Officer & Head of Development | 1,71k | 0,00 | Derivative Exercise and Retained Stock | - | 35,28k | 5,08% |
| 2026-05-15 | Dr. Michael SumnerChief Medical Officer & Head of Development | -680,00 | 884,00 | Derivative Exercise and Sale | 1,30 | 35,28k | - |
| 2026-03-31 | Dr. Michael SumnerChief Medical Officer & Head of Development | 3,07k | 0,00 | Derivative Exercise and Retained Stock | - | 33,58k | 10,06% |
| 2026-03-31 | Dr. Michael SumnerChief Medical Officer & Head of Development | -1,22k | 2,13k | Derivative Exercise and Sale | 1,74 | 33,58k | - |
| 2026-02-26 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | 7,28k | 0,00 | Derivative Exercise and Retained Stock | - | 39,90k | 22,31% |
| 2026-02-26 | Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board | -5,10k | 9,13k | Derivative Exercise and Sale | 1,79 | 39,90k | - |
| 2026-02-26 | Mr. Peter D. KiesCFO | 6,39k | 0,00 | Derivative Exercise and Retained Stock | - | 37,02k | 20,84% |
| 2026-02-26 | Mr. Peter D. KiesCFO | -9,26k | 16,57k | Derivative Exercise and Sale | 1,79 | 37,02k | - |
| 2026-02-26 | Dr. Jacqueline E. SheaCEO, President & Director | 25,32k | 0,00 | Derivative Exercise and Retained Stock | - | 85,00k | 42,42% |
| 2026-02-26 | Dr. Jacqueline E. SheaCEO, President & Director | -21,71k | 38,87k | Derivative Exercise and Sale | 1,79 | 85,00k | - |
| 2026-02-26 | Dr. Michael SumnerChief Medical Officer & Head of Development | 12,66k | 0,00 | Derivative Exercise and Retained Stock | - | 30,51k | 70,91% |
| 2026-02-26 | Dr. Michael SumnerChief Medical Officer & Head of Development | -3,90k | 6,99k | Derivative Exercise and Sale | 1,79 | 30,51k | - |
| 2026-02-26 | Dr. David B. WeinerMember of the Scientific Advisory Board & Director | 972,00 | 0,00 | Derivative Exercise and Retained Stock | - | 87,59k | 1,12% |
| 2025-06-30 | Dr. Michael SumnerChief Medical Officer & Head of Development | 2,92k | 0,00 | Derivative Exercise and Retained Stock | - | 17,85k | 19,53% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
